Skip to main content

Topic

Biotech

242 published works

  1. Big Molecule Watch

    Armed Cell Therapeutics Acquires Preclinical CAR-T Portfolio from Lakefront

    By Alison Siedor

    On October 14, 2026, Armed Cell Therapeutics BV (“Armed Cell”) announced that it acquired a portfolio of preclinical CAR-T assets from Lakefront Biotherapeutics NV (“Lakefront”), formerly Galapagos NV. The two…

  2. Duane Morris Life Sciences Law

    When Does Tissue Processing Cross the Regulatory Line and Require Pre-Market Review?

    By Frederick R. Ball

    By Frederick R. Ball, Coleen W. Hill and Kelechi AnyatonwuFor developers of human cells, tissues, and cellular and tissue-based products, classification can determine the shape of an entire regulatory strategy…

  3. Sanctions & Export Controls Update

    China Proposes Expanded Export Controls on AI, Biopharma and Solar Energy Technologies

    By Zhenyu Ruan (China), Frank Pan (China), Tina Li (China), Chris Jiang (China)

    Overview and key takeaways On 16 October 2026, the Ministry of Commerce of the People’s Republic of China (“MOFCOM”) and the Ministry of Science and Technology of the People’s Republic…

  4. Big Molecule Watch

    Sanofi and Regeneron Expand Immunology Collaboration in Deal Worth Up to $8 Billion

    By Emma Murray

    On October 1, 2026, Sanofi and Regeneron Pharmaceuticals, Inc. (“Regeneron”) announced an expansion of their existing immunology collaboration to develop and commercialize four long-acting antibodies. Sanofi will pay Regeneron $1…

  5. Joe Raczynski | Technologist

    The Exponential Trap: Why Your Brain Can’t See What AI Does Next

    By Joseph Raczynski

    For years, whether recording episodes in the studio, drafting analyses on emerging tech, or speaking to audiences across the globe, I have chased the inflection points where innovation collides with…

  6. The Pre-Flight Brief

    Hospitals Find Biotech Makes a Critical Partner in IP Litigation Article Featuring Ray Panneton

    By Shackelford

    Oct. 8, 2026, 4:00 AM CDT Lauren Castle | Correspondent Dr. Omid Farokhzad and his fellow researchers worked to identify specific proteins functioning as biomarkers for diseases while completing his…

  7. Joe Raczynski | Technologist

    Escaping Flatland: Biological World Models and the Laplace Engine

    By Joseph Raczynski

    Cambridge, MA – MIT Media Lab – EmTech Future. More than two centuries ago, the French polymath Pierre-Simon Laplace conceptualized a powerful scientific thought experiment that would become known to…

  8. Joe Raczynski | Technologist

    Beyond the Wet Lab Bottleneck: The Race to Build Biology’s Generative Engine

    By Joseph Raczynski

    Cambridge, MA – MIT Media Lab – EmTech Future. Nature has spent roughly 3.8 billion years conducting the most sprawling, creative research and development campaign in history. Evolution engineered millions…

  9. Big Molecule Watch

    Dualitas Therapeutics and Roche Enter Research Collaboration to Discover and Develop Bispecific Antibodies

    By Zachariah Holmes

    On September 17, 2026, Dualitas Therapeutics, Inc. (“Dualitas”) announced a research collaboration and license agreement with Roche to advance novel bispecific antibodies (“BsAbs”) for immunology and inflammation diseases, using Dualitas’…

  10. Big Molecule Watch

    GSK to Acquire Trispecific T Cell-Engager for Multiple Myeloma from Chimagen Biosciences

    By Zachariah Holmes

    On September 15, 2026, GSK plc (“GSK”) announced that it agreed to acquire a trispecific T cell-engager (“TCE”) from Chimagen Biosciences (“Chimagen”), a privately held biotechnology company. GSK plans to…